Influenza virus mutants and uses therefor
AssigneeFluGen, Inc.
InventorsPamuk Bilsel, Yasuko Hatta
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
Claims10
A method for immunizing a subject, comprising:
- administering a composition comprising a recombinant influenza virus, wherein the recombinant influenza virus comprises SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3.
A method for reducing the likelihood or severity of infection by influenza A virus in a subject comprising:
- administering a composition comprising a recombinant influenza virus, wherein the recombinant influenza virus comprises SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3.
A method for intracutaneous administration of an immunogenic composition comprising:
- (a) providing a microneedle delivery device comprising (i) a puncture mechanism;
- (ii) an immunogenic composition layer comprising a plurality of microneedles capable of puncturing skin and allowing an immunogenic composition to be administered intracutaneously;
- and
- (b) depressing the puncture mechanism;
- wherein the immunogenic composition comprises a recombinant influenza virus comprising, wherein the recombinant influenza virus comprises SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3.
Dependencies are inferred from the claim text.